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Abstract
Mutations in the CLRN1 gene cause Usher syndrome type 3 (USH3), a human disease characterized by progressive blindness
and deafness. Clarin 1, the protein product of CLRN1, is a four-transmembrane protein predicted to be associated with
ribbon synapses of photoreceptors and cochlear hair cells, and recently demonstrated to be associated with the
cytoskeleton. To study Clrn1, we created a Clrn1 knockout (KO) mouse and characterized the histological and functional
consequences of Clrn1 deletion in the retina and cochlea. Clrn1 KO mice do not develop a retinal degeneration phenotype,
but exhibit progressive loss of sensory hair cells in the cochlea and deterioration of the organ of Corti by 4 months. Hair cell
stereocilia in KO animals were longer and disorganized by 4 months, and some Clrn1 KO mice exhibited circling behavior by
5–6 months of age. Clrn1 mRNA expression was localized in the retina using in situ hybridization (ISH), laser capture
microdissection (LCM), and RT–PCR. Retinal Clrn1 transcripts were found throughout development and adulthood by RT–
PCR, although expression peaked at P7 and declined to undetectable levels in adult retina by ISH. LCM localized Clrn1
transcripts to the retinas inner nuclear layer, and WT levels of retinal Clrn1 expression were observed in photoreceptor-less
retinas. Examination of Clrn1 KO mice suggests that CLRN1 is unnecessary in the murine retina but essential for normal
cochlear development and function. This may reflect a redundancy in the mouse retina not present in human retina. In
contrast to mouse KO models of USH1 and USH2, our data indicate that Clrn1 expression in the retina is restricted to the
Mu¨ller glia. This is a novel finding, as most retinal degeneration associated proteins are expressed in photoreceptors, not in
glia. If CLRN1 expression in humans is comparable to the expression pattern observed in mice, this is the first report of an
inner retinal protein that, when mutated, causes retinal degeneration.
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Introduction
Usher syndrome (USH) is characterized by bilateral combined
blindness and deafness, and is the most common cause of the dual
sensory deficit [1]. To date, there are 11 chromosomal loci with 9
genes identified, and over 100 mutations directly associated with
USH (for reviews see [2–4]). Although significant variability is
present and misdiagnosis is prevalent [5–7], USH has for many
years been sub-categorized into USH1, USH2, and USH3, based
upon the patient’s phenotypic severity and age of onset, as well as
the presence or absence of vestibular function [2,8]. For example,
USH1-associated mutations in myosin VIIa, cadherin, protocad-
herin, harmonin, and SANS result in congenital deafness and
progressive retinitis pigmentosa (RP) beginning before puberty. In
contrast, mutations in the USH2 genes, USH2A and GPR98, result
in moderate to severe congenital hearing loss, normal vestibular
function, and progressive RP. USH3 exhibits progressive post-
lingual hearing loss with a late-onset RP [9], which has recently
been shown to progress more rapidly than USH2A [10,11].
Although having the lowest clinical incidence of the three Usher
syndromes, USH3 has the greatest therapeutic ‘window’ for
treatment due to the relatively late onset and slow progression of
vision loss. More importantly in terms of therapy, human USH3
hearing loss is progressive, in contrast to congenital hearing deficits
in USH1 and USH2. A single USH3 gene, CLRN1 (USH3A), has
been identified [12–15] to date, although there is a putative
additional locus on chromosome 20 [2,16]. The incidence of
USH3 is increased in Finland [9] and amongst Ashkenazi Jews in
various regions [17] due to distinct founder mutations. Twelve
CLRN1 mutations have been documented [6,10,12–14,17–19],
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with the two founder mutations being N48K and Y176X [17]; the
former amino acid change eliminates the only predicted N-linked
glycosylation site, while the latter results in a premature CLRN1
truncation.
Several mouse models of Usher syndrome types I and II have
been characterized [20], with only the Usherin null (Ush2a) mouse
demonstrating a significant retinal degeneration phenotype. The
Ush2a mutant mouse exhibits a very slow, late-onset retinal
degeneration [21]. It remains unclear as to why mutations in USH
genes other than Usherin do not result in a retinal degeneration
phenotype in mice.
Clarin 1 is a unique protein with homology to other four-pass
transmembrane proteins, including members of the Claudin,
Connexin, and CACNG protein families [12]. Based on homology
between CLRN1 and stargazin, as well as its structural similarity
to synaptic cleft and gap junction proteins, CLRN1 was predicted
to be localized to the region around specialized ribbon synaptic
junctions in both photoreceptor and hair cells. Three recent
studies have provided some insight into the primary cochlear
defect [22] and CLRN1’s cytoskeletal cellular binding partners
[23,24]. In the current study, we characterized the expression
pattern of Clrn1 in the murine retina and analyzed the phenotype
of the Clrn1 KO mouse.
We show here that the loss of CLRN1 results in progressive
degeneration and loss of cochlear hair cells and early-onset hearing
impairment. Moreover, and in contrast to recent immunohisto-
chemical evidence [24], we find no evidence that Clrn1 is expressed
in murine photoreceptors and no ‘‘USH3-like’’ retinal degeneration
phenotype in the Clrn1 KO mouse. We believe that CLRN1 may
represent the first Mu¨ller cell-expressed protein which, when
mutated, results in an RP phenotype in humans.
Results
Molecular Expression of Clrn1
RT-PCR analysis of Clrn1 expression in mouse retina is shown in
Figure 1. A diagram of the mouse Clrn1 gene structure is illustrated in
Figure 1A. Clrn1 transcripts (Ensemble; http://www.ensembl.org/
Mus_musculus/Gene/Summary?g=ENSMUSG00000043850) are
encoded by four exons spanning 40 kilobases on chromosome 3. Also
shown in Figure 1A is the intron-spliced four-exon cDNA structure of
the gene. All known transcripts include exons 1 and 4, and the two
primary transcripts in the retina and cochlea both lack exon 2 (shown
in light gray). The longer transcript includes exons 1, 3, and 4
(NM_153385; http://www.ncbi.nlm.nih.gov/nuccore/68533238),
while the shorter splice variant contains exons 1 and 4 only
(NM_153386; http://www.ncbi.nlm.nih.gov/nuccore/68533243)
(see also [22,24]). Primers (Figure S1) used to amplify Clrn1 in all
figures are noted above (forward; sense; F1-F4) and below
(reverse; antisense; R1-R6) the cDNA diagram. Figure 1B shows
adult mouse retinal cDNA amplified with a common Clrn1
forward (F2) and exon-specific reverse (R2-R6) primers,
annealing to each of the 4 exons. Two major Clrn1 splice
variants are readily amplified from retinal cDNA using primers
that span all four exons (lanes 1 and 5). The two Clrn1 splice
variants are distinguished by the inclusion of an alternatively
spliced exon 3 (180 bp), and previously both transcripts have
been shown to be expressed in the mouse inner ear [12,22,24].
The ‘‘full-length’’ transcript contains exons 1, 3, and 4 (upper
bands, lanes 1 and 5), while the shorter splice variant includes
exons 1 and 4 only (lower bands, lanes 1 and 5). Reverse primers
annealing to exons 1 (lane 2), 3 (lane 4), and 4 (lane 5) readily
amplify Clrn1 transcripts, whereas a primer annealing to the
infrequently included exon 2 (previously referred to as exon 1
[12]) shows very low, but detectable, amplification (lane 3).
Together these data indicate that exon 2 is routinely spliced out
of the mature transcripts.
Quantitative (q) RT-PCR (Figure 1C, graph) utilizing dual-
labeled fluorescent probes that anneal to specific exon-exon
junctions (exons 1/3 or 1/4) allowed assessment of the relative
expression levels of the two major transcripts. Six retinas from WT
C57BL/6J animals (3 males, 3 females) were individually
processed for both real-time RT-PCR and end-point (30–40
cycles) RT-PCR. Quantitatively (Figure 1C), the 1/4 exon splice
variant (lacking exons 2 and 3) is expressed at approximately 40%
of full-length (exons 1, 3, and 4) transcript expression levels. The
gel image (Figure 1C, inset) shows an ethidium bromide stained
agarose gel reflecting Clrn1 end-point RT-PCR processed in
parallel for the six animals.
Clrn1 was readily amplified in all postnatal (P) to adult retinal
samples throughout mouse development (Figure 1D). Using a pair
of primers that span exon 1 (F2) to exon 4 (R2), the two major
transcripts were readily detected from the day of birth (P0) through
the first postnatal week (P7), as well as in a P12 and the adult
mouse. Prenatal Clrn1 expression was detectable at embryonic (E)
day 12 (Figure 1E) using semi-quantitative RT-PCR and primers
that span introns. Earlier embryonic stages were not examined.
Similar to findings in the inner ear [12], Clrn1 expression is noted
at all developmental ages tested, with slightly higher expression
levels observed in the E15 animal (both embryo and whole head
samples; Figure 1E). More specifically, embryonic eyes and
dissected retinas were examined by RT-PCR (Figure 1F). Clrn1
is clearly expressed in the eyes (and retinas) of animals before birth.
Omission of the reverse transcriptase (RT) enzyme resulted in no
amplification (Figure 1F). Clrn1 expression was also examined in
the mouse brain (Figure 1G). All brain regions tested showed Clrn1
amplification. In contrast to neural and sensory tissue samples,
amplification of Clrn1 transcripts was not apparent in all body
tissues or organs (Figure 1H). Clrn1 was present in kidney, liver,
skeletal and heart muscle, and below detection in pancreas, spleen,
small intestine, and thymus samples. These data are complemen-
tary to previously published data [12–14].
Author Summary
Usher syndrome (USH) is a progressive disease affecting
two primary senses: vision and hearing. Often by the third
decade of life, affected persons have lost the majority of
their rod photoreceptors, which leads to night blindness
and peripheral vision loss. Similarly, hearing loss often
progresses into the third or fourth decade. By the fourth
decade, patients typically approach legal blindness and
hearing impairment continues to decline. The proteins that
when mutated cause USH are frequently found in primary
sensory cells, photoreceptor and hair cells, that directly
respond to light and sound, respectively. Similar to other
forms of USH, the mRNA coding for the protein
responsible for USH type 3 (CLRN1) is expressed in
cochlear hair cells of the inner ear. However, as demon-
strated in the current study, and unlike other USH disease
proteins in the retina, we show that the Clrn1 is expressed
in glial cells in the retina (Mu¨ller cells) and is not expressed
in the photoreceptors themselves. For reasons that remain
unclear, the Clrn1 knockout mouse does not have a retinal
degeneration phenotype but does become deaf soon after
birth. In the current paper, we characterize the expression
pattern in the retina and analyze the effects of removing
the Clrn1 gene on vision and hearing.
Clarin 1 Is Necessary for Hearing but Not Vision
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Generation of the Clrn1 Knockout Mouse
A schematic diagram of the genetic recombination used to
generate the Clrn1 KO mouse is shown in Figure 1I. We
eliminated the production of all known coding transcripts in the
eye and ear by utilizing Cre recombinase and loxP sites to
recombinatorily remove part of the gene promoter, the transcrip-
tional start site (TSS), the entire first coding exon including the 59
UTR and starting ATG, and a small portion of the 1st intron
(collectively labeled with an asterisk; Figure 1I).
Heterozygous animals on a C57BL/6 background were mated
and provided viable WT, heterozygous Clrn1 KO (+/2), and
homozygous Clrn1 KO (2/2) progeny. Figure 1J shows retinal
RT-PCR analysis of littermate WT and Clrn1 KO (homozygous
and heterozygous) animals. Using primers (F2/R2) that span from
exon 1 to exon 4, both primary transcripts were observed in both
WT (+/+) and Clrn1 heterozygous (+/2) animals, whereas no
amplification was observed in the homozygous (2/2) Clrn1 KO
animals. Furthermore, although this was not a quantitative assay,
it is apparent that the WT mouse expressed more than either
heterozygous animal. Moreover, no amplification was apparent
when the RT enzyme was omitted from the cDNA synthesis
reaction, ensuring that positive amplification was due to Clrn1
mRNA expression and not genomic DNA contamination.
Inner Retinal Expression of Clrn1
In contrast to all other known disease-causing mutations
resulting in retinitis pigmentosa (RP), Clrn1 mRNA expression
was restricted to the inner nuclear layer (INL) of the retina, and
was undetectable in photoreceptor or retinal pigmented epithelial
(RPE) cells. This was an unexpected and unusual result, and to the
authors’ knowledge, this is the first time that a mutant protein
produced by the inner retina results in an RP phenotype.
In situ hybridization was performed with a Clrn1 riboprobe on
developmental retinal tissue from both WT and Clrn1 KO mice
(Figure 2). In WT animals, Clrn1mRNA was not detected at E18.5
Figure 1. Clrn1 RT–PCR analysis in mouse retina and KO mouse
generation. (A) Schematic diagram illustrating the intron/exon
structure of the murine Clrn1 gene, and the structure of the spliced
transcripts showing primer locations. (B) Two transcripts are readily
amplified from mouse retina. A common forward primer (F2) was paired
with exon-specific reverse primers (R2-R6; see Figure S1) in lanes 1–5.
(C) Quantitative RT–PCR analysis comparing major splice variant
expression levels in 6 adult C57BL/6J mouse retinas (3 male, 3 female),
using F3/R1 primers and fluorescent FAM-BHQ probes (see Figure S1)
specific for exon 1/3 or exon 1/4 splice junctions. The inset gel image
shows end-point RT-PCR analysis of the same samples using F2/R2
primers. (D) Postnatal developmental and adult expression of Clrn1
using F2/R2 primers. (E) Prenatal developmental expression of Clrn1.
Whole embryos, heads, and brain tissue RNAs were amplified using F1/
R1 primers. (F) RT–PCR analysis of isolated prenatal eyes, a P21 retina, an
adult control retina, and a No RT (no reverse transcription) negative
control using F1/R1 primers. (G) Regional expression in the adult mouse
brain is demonstrated (F1/R1 primers). All brain regions appear to
transcribe the Clrn1 gene. (H) Clrn1 expression in adult mouse organs
(F1/R1 primers). A more restricted expression profile is evident in mouse
tissues outside of the nervous system, similar to expression in human
[12]. (I) The 59 untranslated region (59 UTR), exon 1 (containing the
transcriptional start site (TSS) and the ATG start codon), and the
proximal 269 bp of the first intron were removed in embryonic stem
cells by homologous recombination. The uppermost construct repre-
sents a 50,000 bp genomic fragment on chromosome 3q21, while the
two lower constructs represent approximately 20,000 bp centered on
exon 1. The genomic region (*) and neomycin resistance gene (NeoR)
were spliced out by Cre recombinase activity at loxP (P) sites. (J) RT–PCR
analysis of Clrn1 total KO (2/2), littermate heterozygous controls (+/2),
and WT (+/+) animals using F2/R2 primers. No RT = no reverse
transcription. (+) = Plasmid DNA containing cloned Clrn1 cDNA (exons
1, 3, and 4).
doi:10.1371/journal.pgen.1000607.g001
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(Figure 2A), P0 (Figure 2B), or P3 (Figure 2C). However, antisense
riboprobe labeling of INL cells was unambiguous at P7 (Figure 2D
and 2E). As expected, retinal tissue from the KO animal
(Figure 2F) showed no labeling. Clrn1 ISH was clearly detectable
at P7 in the INL (Figure 2G). However, Clrn1 expression is
subsequently down-regulated (Figure 2I) and not detectable by 4
weeks of age in WT mouse retina (Figure 2K), although all ages
show expression by end-point PCR (Figure 1). Hybridization with
a sense (control) riboprobe showed no labeling at any age
(Figure 2H, 2J, and 2L). ISH with a Clrn1 riboprobe on adult
human retina did not generate a significant signal (data not
shown). We were unable to obtain human retina at the equivalent
stage of fetal development (third trimester) to the peak of labeling
observed in the mouse retina (P7).
To follow up on inner retinal localization of Clrn1 by ISH in
WT retinal tissue (Figure 3), we performed immunohistochemistry
to clarify which retinal cell type(s) express Clrn1. The blue-purple
ISH reaction product represents Clrn1 mRNA, whereas red and
green fluorescence indicates immunohistochemical staining. An
antibody (TuJ1) to tubulin type III labeled all neuronal elements in
the retina (shown in red; Figure 3B, 3C, 3E, and 3F). Dual labeling
indicates that TuJ1 and Clrn1 lack co-localization, and thus are not
co-expressed in neuronal cells. We also double-labeled P7 retinal
sections for Clrn1 ISH and Sox9 immunohistochemistry
(Figure 3G–3J). Sox9 is a transcription factor that is widely
expressed in retinal progenitor cells during development. Sox9
expression is maintained in Mu¨ller cells but lost in maturing
neurons [25]. In peripheral retina, the antibody to Sox9 (red)
labeled a band of retinal progenitor and Mu¨ller glia (Figure 3G
and 3H). In the more differentiated central retina, a narrower
band of Clrn1 ISH-positive cells (Figure 3I) is apparent, and some
of these cells also stain positively for Sox9 (Figure 3J; red) and
Glast (Figure 3J; green). These data add additional support to the
identification of Mu¨ller cells as the predominant source of Clrn1
expression in the retina. Additionally, staining of P7 mouse retina
shows co-labeling of Clrn1 ISH with a Glast antibody (Figure S2).
Double labeling with Glast, a Mu¨ller glial cell marker, indicates
that some Glast-positive cells also express Clrn1 mRNA.
Surprisingly, these data show that Clrn1 mRNA (and presumably
the protein product(s) of the Clrn1 gene) is expressed in retinal glia
and not in neurons, including photoreceptors.
We performed two additional experiments (Figure 4 and
Figure 5) in order to validate our ISH data shown in Figure 2
and Figure 3. We first used a genetic approach and examined a
well-studied model of photoreceptor degeneration: the C3H/HeJ
(C3H) mouse, which harbors the photoreceptor Pde6brd1 mutation
[26]. The mutation results in a rapid degeneration and loss of
nearly all photoreceptor cells [27,28]. A histological comparison of
a 6-month-old WT C57BL/6J and a 14-month-old C3H mouse is
shown in Figure 4A and 4B, respectively. Note the maintenance of
the GCL and INL, but near complete loss of the ONL in the C3H
animal (Figure 4B). We performed qRT-PCR and normalized the
WT and C3H samples to the ganglion cell-specific transcript,
Thy1, as well as to 28S RNA. We also measured the expression
levels (Figure 4C) of six genes in addition to Clrn1 and Thy1: cFos,
Slc1a3, Grm1, Rho, Rp1, and Vim. When compared to expression
levels in the WT animal, the loss of photoreceptors resulted in
reduced expression of the immediate early gene transcription
factor cFos, as well as Slc1a3 and Grm1, a glutamate transporter and
receptor, respectively. Not surprisingly, extremely low levels of the
photoreceptor-specific transcripts Rho and Rp1 were measured in
the C3H mutants. These data confirm our histological observa-
tions that photoreceptors are for all intents and purposes absent or
completely degenerated in the C3H animals. Importantly, as
measured with two independent primer pairs, Clrn1 exhibited
essentially no difference in expression in the C3H retinas
(Figure 4C; Clrn1 (1), Clrn1 (2)) compared to the WT sample.
The vimentin (Vim) transcript (Figure 4C) appeared to be slightly
up-regulated in both degenerated C3H retinas, a finding
consistent with other models of photoreceptor degeneration [29].
Figure 4D shows relative WT expression levels of the 28S/Thy1-
normalized transcripts (Figure 4C). In Figure 4D, the averaged
raw Ct (threshold cycle number) data for each transcript were
normalized such that Clrn1 expression was assigned an expression
level of 1. Though not quantitative, these data provide
approximations of the relative abundance of genes in WT animals
compared in Figure 4C. Hence, 28S and Rho express roughly
10,000 and 8,000 times the number of Clrn1 transcripts,
Figure 2. Developmental time course of Clrn1 in situ hybrid-
ization in the mouse retina. (A–C) Clrn1 was not detected in sections
of E18.5 (A), newborn (B), or P3 (C) mouse retina. (D) Clrn1 in situ
labeling in the INL (arrows) of a P7 retina. (E) Clrn1 in situ showing
labeling across the entire central-to-peripheral extent of the retina at
P7. (F) Section from a Clrn1 deficient mouse retina showing lack of
labeling. (G,H) Clrn1 anti-sense (G) and sense control (H) hybridizations
showing expression at P7 (arrows). (I,J) Clrn1 anti-sense (I) and sense
control (J) sections from a P12 retina, showing a lower level of
expression by this age (arrows). (K,L) Clrn1 expression at 4 weeks of age.
No signal above the sense control (L) could be detected at this age. All
sections were hybridized with the same probe and reacted for similar
lengths of time. Scale bars = 100 mm for all images except (E), where the
scale bar = 200 mm. Scale bars: In A applies to A–C; in D applies to D and
F; in G applies to G–J; in K applies to K–L. NBL= neuroblastic layer,
CB = ciliary body, ONL=outer nuclear layer, INL = inner nuclear layer,
GCL =ganglion cell layer, and RPE = retinal pigmented epithelium.
doi:10.1371/journal.pgen.1000607.g002
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respectively. Rp1, another photoreceptor-specific transcript ex-
presses about 200-fold higher levels, while Thy1 expresses about 15
times the number of Clrn1 transcripts. Finally, Vim mRNA is
expressed at a roughly similar level, while significantly fewer cFos,
Slc1a3, and Grm1 transcripts are expressed in the WT mouse
retina.
A similar genetic experiment (Figure S3) was performed using
the Proline-23-Histidine line 3 (P23H-3) rhodopsin mutant and
Royal College of Surgeons (RCS) mutant rats [30,31]. Analogous
to the mouse, histological analysis shows a near complete loss of
photoreceptors in the P23H-3 rat (Figure S3B) compared with the
WT retina (Figure S3A). In both rat retinal degeneration models
Rp1 expression is almost completely lost, indicating a near total
loss of photoreceptors (Figure S3C and S3D). When equivalent
total amounts of whole retinal cDNA were PCR amplified
(without normalization), P23H-3 and RCS retinal samples show
a relative increase in Clrn1 expression compared to control retinas.
The apparent increase in Clrn1 expression is due to the loss of the
photoreceptor RNA contribution to the total RNA samples from
mutant animals when equal amounts (from WT and mutant
retinas) were included in the amplification reactions. This
apparent change in expression is quantified by qRT-PCR (Figure
S3E) and represents the average of two retinas. These data suggest
that approximately 75% of total retinal RNA in WT animals is
produced by photoreceptors, resulting in a ,4-fold apparent
increase in Clrn1 expression when photoreceptors are absent from
the mutant retinal samples.
In a complementary experiment, we used LCM (Figure 5) to
isolate mRNAs from individual nuclear layers from WT mouse
retinal sections. Micrographs (Figure 5A–5F) show the progression
of laser capture sample collection. Red spots (Figure 5A–5E) show
the location of the laser beam used to select each of the three
individual nuclear layers: ONL, INL, and GCL. Figure 5A shows
the retinal section before laser irradiation and Figure 5B shows the
retina after the tissue was laser-selected (but not removed).
Following removal, the selected/collected tissue (photoreceptors;
ONL) was observed on the underside of the tube cap (Figure 5C).
Figure 5D and 5E represent capture of the INL and GCL,
respectively, while Figure 5F indicates the retinal tissue that
remained after the collected cells were physically removed from
the tissue section. Using LCM, we collected total RNA from each
of the three major retinal nuclear layers (ONL, INL, GCL), and
subsequently subjected the isolated total RNA to RT-PCR analysis
(Figure 5G). Total RNA was extracted and amplified using two
rounds of RT-PCR for Rp1 (a photoreceptor specific transcript)
and Clrn1 (Figure 5G). As expected, robust Rp1 expression was
detected in both ONL samples and absent in the GCL. We believe
that the presence of some Rp1 transcripts in the INL sample is the
result of a few photoreceptors inadvertently adhering to the cap of
INL sample. Nevertheless, Clrn1 was only observed in the INL
sample, and was completely absent from both ONL and GCL
samples, further supporting the restricted INL localization of Clrn1
transcripts (Figure 2, Figure 3, and Figure 4).
Figure 3. In situ hybridization and immunohistochemistry
localize Clrn1 expression to Mu¨ller cells in P7 mouse retina.
(A–C) A section of WT retina labeled for Clrn1 (A) and the neural marker
TuJ1 (C). The merged images (B) show the lack of overlap with the
neural specific marker. TuJ1 labels all inner retinal neurons, but not the
Clrn1-positive cells. (D–F) Higher magnification views of the boxed
region in (B). Arrowhead points out a TuJ1-positive cell that is not Clrn1-
positive, while the arrow points to a cell that is Clrn1-positive but not
TuJ1-positive. (G,H) Peripheral retina labeled with the Clrn1 riboprobe
(G) and subsequently with an antibody to Sox9 (H), a marker of retinal
progenitors and Mu¨ller glia. We find double labeled cells throughout
the peripheral retina. (I) In the central retina, where the last progenitors
are turning into Mu¨ller glia, a thinner row of Clrn1-positive cells remains.
(J) The section shown in (I) was double immunolabeled (after ISH) with
antibodies to Glast (green) and to Sox9 (red). Arrows (I and J) identify
triple-labeled Mu¨ller cells. Scale bars = 50 mm in all images. Scale bars: In
A applies to A–C; in D applies to D–F; in G applies to G–J. ONL= outer
nuclear layer, INL = inner nuclear layer, GCL=ganglion cell layer.
doi:10.1371/journal.pgen.1000607.g003
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Retinal Structure in the Clrn1 Knockout Mouse
Clrn1 KO mice show no phenotypic signs of retinal degenerative
disease. Since the USH3 human combined blindness and deafness
phenotype is progressive, we studied Clrn1 KO mice up to 2 years.
At 2 years of age, Clrn1 KO mice continued to exhibit a normal
retinal phenotype, both structurally and functionally. Figure 6 is
toluidine blue stained 1 mm plastic embedded sections of 9 month
old WT (+/+) and Clrn1 mutant (+/2,2/2) animals. Figure 6A–
6C show high magnification of the photoreceptors and their
associated RPE, while Figure 6D–6F show the inner retina at the
same magnification. Lower magnification offers a more gross
histological view of mid-peripheral (Figure 6G–6I) retina, as well as
retina immediately adjacent to the optic nerve head (asterisks,
Figure 6J–6L). No abnormal histological phenomena were detected.
We performed fluorescent confocal microscopy using a panel of
antibodies to look for subtle structural or cellular changes in the
Clrn1 KO retina (Figure 7). Eighteen month old littermate animals
(WT and KO (2/2)) from early heterozygous matings were used.
Antibodies used were: anti-Calbindin (horizontal and amacrine
cells; Figure 7A–7D), anti-PKCa (rod bipolar cells; Figure 7E–7H),
Rhodamine-PNA (cone photoreceptor sheaths; Figure 7I and 7J),
anti-synaptophysin (OPL and IPL synaptic structures; Figure 7K
and 7L), anti-GFAP and anti-vimentin (glial cells; Figure 7M–7P),
and a chicken anti-CLRN1 antibody (Clarin160; Figure 7Q and
7R. See below, and Figure S4 and Figure S5). No differences
between WT and Clrn1 KO (2/2) animals were found using these
antibodies. Due to low levels of retinal CLRN1 expression, the
anti-CLRN1 antibody labeling (Figure 7Q and 7R) represents
non-specific signal in both WT and Clrn1 KO retinas. Labeling
with the secondary antibodies alone showed no reactivity
(Figure 7S and 7T). It is important to note that when an EGFP-
CLRN1 fusion protein is overexpressed in 293 cells (see below,
and Figure S4), specific labeling is readily observed using two
different anti-CLRN1 antibodies, including the Clarin160 anti-
body immunoreactivity shown here (Figure 7Q and 7R).
Clarin 1 Antibody Analysis and Membrane Localization in
Transfected Cells
Using the pEGFP-C1 vector (Clontech), we generated and
expressed the EGFP-CLRN1 fusion protein in HEK293 cells
Figure 5. Laser capture microdissection of WT mouse retina.
(A–F) Images of a section of WT C57BL/6J retina taken during the laser
capture process. (A) Retina before laser capture. (B) The ONL is being
captured on the cap. (C) The ONL after capture, on the surface of the
microfuge tube cap just prior to total RNA extraction. (D) The ONL has
been removed, and the INL is being laser-captured. (E) The ONL and INL
have both been removed (though some cells remain), and the GCL
(ganglion cell layer) is being laser captured. (F) Retina remaining after
cell layers have been laser captured and collected on microfuge tube
caps. (G) RT–PCR was used to amplify Rp1 (a photoreceptor specific
transcript) and Clrn1 in each sample. Rp1 was detected in both ONL
samples as well as the INL sample due to carry-over of a few
photoreceptors, but was not detected in the GCL. Note that Clrn1
transcripts were only detected in the INL. Scale bar = 50 mm.
ONL=outer nuclear layer, INL = inner nuclear layer, GCL =ganglion cell
layer, and RPE= retinal pigmented epithelium.
doi:10.1371/journal.pgen.1000607.g005
Figure 4. Analysis of Clrn1 in WT and photoreceptorless C3H/
HeJ aged mouse retinas. (A,B) Sixteen micron cryosections of WT (A)
and degenerated C3H (B) mouse retinas counterstained with hematox-
ylin. Note the virtual complete loss of photoreceptors in the 14 month
C3H retina. (C) Real-time quantitative (q) RT–PCR was performed in
order to correct for the RNA contribution of the outer retina in the WT
cDNA sample. The data were normalized to the ganglion cell marker
Thy1, and subsequently to expression levels in the WT sample. For
comparison purposes, several additional known retinal transcripts were
included in the qRT–PCR analysis. (D) Relative transcript expression
levels in retinas from WT and photoreceptorless animals. Normalizing to
a Clrn1 primer pair, the range in the abundance of non-Clrn1 transcripts
was 100-fold fewer (Grm1) to 10,000-fold higher (Rhod). Scale
bar = 50 mm in all images. ONL=outer nuclear layer, INL = inner nuclear
layer, and GCL=ganglion cell layer.
doi:10.1371/journal.pgen.1000607.g004
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(Figure S4), driven by the human cytomegalovirus (CMV)
immediate early promoter. Transfection with the vector alone
resulted in EGFP expression localized throughout cell somata
(Figure S4A). CLRN1 (containing exons 1, 3, and 4) was fused to
the 39 end of EGFP, and following expression the resultant fusion-
protein was redistributed and concentrated to plasma membranes
(Figure S4B). This finding supports previous predictions based
upon the primary structure[12], as well and recent studies [23],
that full-length murine CLRN1 (232 aa) is predominantly a
plasma membrane-targeted protein.
Anti-CLRN1 antibodies were screened for specificity using
EGFP-CLRN1 transfections in HEK293 cells. With the red
channel turned off, clear EGFP-CLRN1 fluorescence is observed
in a subset of cells (Figure S4C). Red fluorescence (Figure S4D)
Figure 6. Histological analysis of Clrn1 KO retinas at 9 months of age. (A–C) Compared to WT animals (A), outer retinal histology appears
normal in heterozygous (B) and homozygous (C) Clrn1 KO mice. (D–F) Similarly, the inner retina of the Clrn1 KO (+/2,2/2) animals is
indistinguishable from the WT animal (D). (G–L) When compared to WT (+/+) animals (G and J) at lower magnification, gross retinal structure seems
unperturbed by the lack of Clrn1 expression (H,I,K,L) in either mid-peripheral retina (G–I) or central retina (J–L) immediately adjacent to the optic
nerve head (asterisks). Scale bar = 50 mm. ONL=outer nuclear layer, IS = photoreceptor inner segments, OS =photoreceptor outer segments, and
RPE = retinal pigmented epithelium.
doi:10.1371/journal.pgen.1000607.g006
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Figure 7. Immunohistochemical analysis of littermate WT (+/+) and Clrn1 KO (2/2) mouse retinas. (A–D) WT and KO retinas stained with
an antibody to Calbindin, shown at low (A and B) and high (C and D) magnifications. (E–H) WT and KO retinas stained with an anti-PKC-alpha
antibody at low (E–F) and high (G–H) magnifications. (I,J) WT and KO retinas labeled with the rhodamine-conjugated peanut agglutinin (PNA) lectin.
(K,L) WT and KO retinal sections immunostained with anti-Synaptophysin antibodies, shown at high magnification. (M–P) WT and KO retinal sections
stained with intermediate filament antibodies to GFAP (M,N) and vimentin (O,P). (Q,R) Immunostaining with a candidate antibody made to CLRN1
(the Clrn1 gene product) in WT (Q) and KO (R) retinas. (S,T) Control images showing labeling by the secondary antibodies alone. Scale bar = 20 mm in
all images. Scale bars: In A applies to A–B, E–F, I–J, M–N, and Q–T; in C applies to C–D, G–H, and K–L; in O, applies to O–P. INL = inner nuclear layer,
ONL=outer nuclear layer. SYTOX Green was used as the nuclear counterstain.
doi:10.1371/journal.pgen.1000607.g007
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shows subsequent immunostaining with an anti-CLRN1 affinity-
purified antibody (CLRN1-B2). The CLRN1-B2 antibody (rabbit)
showed precise co-localization (Figure S4E) with the EGFP-
CLRN1 fusion protein. In a similar experiment the Clarin160
antibody (chicken), which was generated against a different
CLRN1 peptide, showed equally reliable co-localization with
EGFP-CLRN1 (Figure S4F, S4G, S4H). No immunoreactivity
(red) was detected when the primary antibody was omitted (Figure
S4I, S4J, S4K) or in non-transfected cells (data not shown). Several
additional anti-CLRN1 antibodies showed various degrees of
specific/non-specific labeling (data not shown).
Western blot analysis (Figure S4L) of adult human, mouse, and
rat retinal homogenates using the CLRN1-B2 antibody detected a
band at ,25–26 kDa in all species, and an additional ,35 kDa
protein in the human sample only. Detection was dependent upon
sodium dodecylsulfate (SDS) inclusion in the sample buffer, as no
reactivity was observed in samples processed without SDS (Figure
S4L, right side). We immunoprecipitated CLRN1 from mouse
retinas using the CLRN1-B2 antibody to further characterize the
CLRN1 protein (Figure S4M). After elution and subsequent
immunoblotting with the same antibody, a higher molecular
weight (,55–80 kDa) protein complex was detected prominently
in the first two eluates (lanes 1 and 2). These data indicate that
CLRN1 can homodimerize and/or participate in the formation of
larger multi-protein complexes under non-reducing conditions.
Studies to identify CLRN1 interacting proteins provide additional
insight into CLRN1 function [23], and there have been indications
that CLRN1 associates with both actin [23] and microtubules
[24].
Immunocytochemistry on P7 WT mouse retinal sections (Figure
S5), the peak of Clrn1 mRNA expression as detected by ISH
(Figure 2), failed to show specific CLRN1 localization using
Clarin160 (Figure S5E, S5F) or CLRN1-B2 (Figure S5G, S5H)
antibodies. Similar labeling was observed in both WT and Clrn1
KO control retinal sections for each of the antibodies tested.
Retinal and Cochlear Function
Recent data suggest that Clrn1KO mice are functionally normal
[22]. We independently performed ERG experiments (Figure S6)
in order to measure photoreceptors A- and B-wave function in
WT and Clrn1 KO animals up to 2 years of age. Photoreceptor
function in the Clrn1 KO animal appeared normal, and no
significant difference was observed at any light intensity. In
contrast to the lack of a retinal phenotype, but similar to most
other mouse models of Usher syndrome [20], the Clrn1 KO mouse
exhibits significant structural and functional hearing deficits [22].
Similarly, we demonstrate inner ear dysfunction in the Clrn1 KO
mouse by measuring the auditory brainstem response (ABR).
Figure S7 illustrates representative ABR traces, and corroborates
the functional loss in both juvenile and adult animals [22].
Outer and Inner Hair Cells Degenerate in Clrn1 KO Mice
and Exhibit Longer Stereocilia
Immunofluorescence with a hair cell-specific marker, myosin
VI, and filamentous actin were used to evaluate the cellular
arrangement and general morphology of the auditory sensory
epithelium of WT and Clrn1 KO (2/2) mice (Figure 8). Recently
Clrn1 was shown to be directly associated with the cellular actin
networks [23], so staining for f-actin is particularly interesting in
the Clrn1 KO animals. Figure 8A illustrates the origin of the
cochlear tissue depicting the planes of section used in the analysis
of the organ of Corti (middle and apical turns; side and top views).
At P15, there is no apparent cell loss in the organ of Corti
(Figure 8B and 8C), however, the mechanosensory stereocilia, the
actin-rich projections on the apical surface of the inner hair cells
(IHC) appear disorganized, elongated, and variable in length
(6.0360.51 mm, n=80, P,0.001) when compared to the WT
control (4.6660.174 mm, n= 80) (Figure 8D–8G). Similar non-
quantitative morphological changes in stereocilia have been noted
previously [22]. At P120, the cochlear outer hair cells (OHC) and
IHC, as well as the supporting cells, are severely degenerated
(Figure 8H–8M). By P120, the number of cell bodies is
significantly reduced, and the remaining cells have reduced apical
surfaces and display bundles of severely disorganized and
elongated stereocilia (Figure 8M). The supporting pillar cells,
two closely adjacent rows of epithelial cells that separate the inner
and outer rows of hair cells, appear structurally compromised, as
indicated by a reduction in rhodamine-Phalloidin staining of the
pillar heads (Figure 8I).
Some Clrn1 KO mice on a C57BL/6 background exhibited
circling behavior by 5–6 months of age (Video S1). Circling
behavior was more prevalent when the KO construct was
backcrossed to a mixed C57BL/6 and Sv129 genetic background
(data not shown). However, the circling phenotype remained
incompletely penetrant, irrespective of the genetic background,
consistent with the variable finding of vestibular defects among
USH3 patients. We analyzed filamentous actin features of
utricular cells in vestibule of the randomly selected (non-circling)
4-month WT and Clrn1 KO animals on the C57BL/6 background
(Figure S8). Neither low (Figure S8A, S8B) nor high (Figure S8C,
S8D) power images indicate any grossly abnormal structural
features in the vestibule at P120.
Discussion
Photoreceptors are known to express over 300 unique (within
the retina) transcripts [32], many of which are unlikely to be
expressed outside of the eye. This finding is consistent with clinical
disease manifestations, where mutations (dominant or recessive) in
rod photoreceptor cell-expressed genes commonly result in
photoreceptor cell death and consequent RP. There are
documented examples of RPE-defects [33,34], as well as a
predominantly expressed ganglion cell transcript [35] that result
in an RP-like phenotype. To date, retinal degeneration resulting
from mutation in proteins originating from neurons or glia of the
inner nuclear layer has not been described. Our data suggest that
CLRN1, the protein implicated in Usher syndrome type 3 which
caused progressive blindness and deafness in humans, is an inner
retinal protein (at least in mice) produced by the retinas resident
radial glia, Mu¨ller cells.
Retinitis pigmentosa (RP) is a group of blinding diseases
affecting approximately 1.5 million people worldwide, and around
1 in 4000 births in the United States [36–38]. RP is sometimes
referred to as rod-cone dystrophy, and is characterized by a loss of
rod photoreceptor cells, narrowing of the visual field, and night
blindness, which can eventually progress to cone dysfunction and
total vision loss. Thus far, over 40 loci have been identified for
non-syndromic RP [38] and 30 genes have been causally related
(RetNet; http://www.sph.uth.tmc.edu/Retnet/). In contrast, cone
or cone-rod dystrophies (21 loci, 15 identified genes) are due to
primary defects in cone cells, and in turn, rods may eventually
become vulnerable to progressive degeneration [39]. Usher
syndrome (USH) is fundamentally characterized by combined
deaf-blindness. There are over 50 syndromic/systemic loci
involving RP (RetNet), about 25% of which are also associated
with USH. USH syndromes are the most common cause of this
combined deaf-blindness, accounting for approximately 50%
[1,16], while contributing to about 14% of all RP cases [34].
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Nine of the 11 Usher syndrome loci have been genetically
characterized, with 2 genes (USH1E and USH1H) not yet
identified [4].
Numerous transgenic and knockout mouse models of RP have
been developed, in which a mutation or knockout of a
photoreceptor or RPE specific gene results is an approximation
of the human clinical phenotype, often exhibiting an abbreviated
time course; among these are Rho [40], Pde6b [41], RDS [42],
Rom1 [43], Crx [44], Tub [45], Gucy2e [46], RPE65 [47], and
others. To date, knockout of Usher gene product has been largely
unsuccessful in generating animal models with a retinal degener-
ation phenotype in mice, with only the Usherin null (Ush2a) mouse
demonstrating a significant disease. [20,21]. Surprisingly, the
majority of these USH animal models exhibit pronounced hearing
defects [48–52]. Small alterations in the ERG amplitude and
waveform have been noted in some of these mice [53–55] but the
implications of these changes remain unclear. Overall, relatively
few tetraspanins have been identified as having essential functions,
and mouse knockouts of individual tetraspanins has resulted in
mild phenotypes [56].
The lack of genotype-phenotype correlation in the retina of
USH mouse models remains unclear. In the absence of direct
evidence of a redundant pathway in mice, it is reasonable to
suggest that there is compensation via undiscovered gene products
Figure 8. Cochlear hair cells of Clrn1 KO (2/2) mice degenerate with age and exhibit longer stereocilia. (A) Illustration of the inner ear,
demonstrating the cochlea and auditory sensory epithelium. (B–E) Immunofluorescent confocal images of P15 and mouse inner-ear epithelia
harvested from the middle turn of the cochlea, shown in side view. Filamentous actin was detected with rhodamine-Phalloidin (red), and anti-myosin
VI labeling is shown in green. (B,C) At P15, the auditory epithelium in Clrn1 KO (2/2) (C) mice appears morphologically similar to WT animals (B). (D)
WT animals maintain organized stereocilia on inner hair cells (IHCs). (E) Subtle IHC stereociliar abnormalities such as increased bundling and
lengthening (arrowheads) are evident in KO animals at P15. (F,G) Quantitative analysis of IHC bundle lengths reveal considerably longer stereocilia (F)
in P15 Clrn1 KO animals, distributed over a broader range of lengths (G, upper graph; n = 80), which is distinguishable from the highly uniform lengths
of WT stereocilia (G, lower graph; n = 40). (H,I) Shown from the side view at P120, and compared to WT labeling (H), staining of Clrn1 KO auditory
epithelia (I) indicates extensive degeneration and loss of IHCs. At this age, a disruption of supporting cell apical surfaces is apparent (I, arrowheads),
and the surviving IHCs in the auditory epithelia of Clrn1 KO mice exhibit shortened hair cell bodies (I, arrows). (J,K) From a top view, a clear disruption
and loss of both IHCs and OHCs is evident in the Clrn1 KO mutant (K, arrowheads). (L,M) IHCs from WT cochleas (L) possess highly ordered and
symmetrical stereocilia, while Clrn1 KO IHCs (M) exhibit profoundly disorganized bundles of elongated and possibly fused stereocilia (arrowheads).
* = P,0.001. Error bars = 1 SD. Scale bars: In B (25 mm) applies to B and C; in D (7.5 mm) applies to D and E, in H (25 mm) applies to H and I, in J (20 mm)
applies to J and K, in L (5 mm) applies to L and M.
doi:10.1371/journal.pgen.1000607.g008
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and/or intracellular pathways mitigating the loss of USH gene
expression in the mouse retina. USH proteins in the retina are
generally thought to be localized to photoreceptor and/or RPE
cells. USH proteins are commonly associated with photoreceptor
connecting cilia, inner/outer segments, and synaptic regions
[2,3,16]. Indeed, recent immunohistochemical evidence purports
CLRN1 to be localized to photoreceptors [24], and it remains
unclear how to harmonize these data with our findings presented
here, where we show that Clrn1 is not expressed in photoreceptors.
Nevertheless, it has been proposed that USH proteins form a
network of directly associated proteins within the cell, localizing at
or near the photoreceptor’s connecting cilium, at the apical part of
the inner segment [3,16,57,58]. It follows then that damage to any
one of the proteins within the complex could theoretically result in
clinically similar USH-related RP phenotypes. Though some USH
gene products localize to the synaptic terminal, there is little
evidence for synaptic zone dysfunction in human electrophysio-
logical recordings [10,59]. Indeed, our original hypothesis
maintained that CLRN1 would be a protein facilitating structural
maintenance of the synaptic connection between photoreceptors
and second order neurons, horizontal and bipolar cells [12].
However, this hypothesis is not supported by data presented here.
Developmental Expression of the Murine USH3A Gene
Clrn1
We demonstrated by RT-PCR that Clrn1 is readily amplified
from a variety of adult mouse tissues, all examined brain regions,
and the retina. Two primary transcripts were expressed at an
approximate 5:2 ratio; the primary transcript includes exons 1, 3,
and 4, while lower levels of expression are observed for the splice
variant including exons 1 and 4. This is consistent with the
expression of Clrn1 splice variants in the inner ear [12]. The
purpose of inclusion/exclusion of exons 3 and/or 2 in mature
Clrn1 transcripts remains unclear; as is the significance of Clrn1
splice variant expression levels. Nevertheless, the expression levels
of the splice variants appear to be consistently regulated. Based on
topological predictions [12] the shorter splice variant (without
exon 3) would lack two of the four predicted transmembrane
domains if translated into a functional protein. Thus, it is
interesting to consider the possibility that the shorter splice variant
may exhibit distinct biophysical properties and/or functions from
its longer, four transmembrane ‘‘full-length’’ counterpart.
Our results show that although Clrn1mRNA can be readily RT-
PCR amplified from embryonic, juvenile and adult retina, the
mRNA is developmentally down regulated in adult mice. These
data suggest that CLRN1 (protein) expression is likely to decrease
over the course of retinal maturation, and that CLRN1 is probably
translated and expressed at comparably low levels in the adult
mouse. It may be that CLRN1 is non-essential to the adult mouse
retina, and that CLRN1 serves only a transient (and presumably
non-deleterious) role during murine retinal development. We do
not currently have CLRN1 expression data from developing or
adult human retina. However, it is intriguing to postulate that the
CLRN1 gene may be differentially regulated in humans. If, in fact,
human regulation differs from the mouse with respect to Clrn1
gene expression, and human retina exhibits (or requires) robust
and/or continuous expression into adulthood, it seems reasonable
to postulate that humans may develop the characteristic age-
related USH3 retinal phenotype whereas mice do not. In other
words, humans, but not mice, may have maintained and/or
evolved a need for continuous CLRN1 expression in the retina.
Another important possibility to consider is that mice, but not
humans, express a compensatory protein or utilize a redundant
functional pathway that obviates the need for CLRN1 in the
mouse retina. Finally, it also seems reasonable to suggest that
degeneration in the mouse retina could be dependent upon the
expression of gain-of-function mutant CLRN1 proteins, and not
simply the loss of CLRN1 altogether, as in the case of the total
KO. In this case, the mouse cochlea would remain sensitive to
either the absence (KO) or mutation (point mutation or
truncation) of CLRN1, whereas the retina would be insensitive
in the KO condition, but would degenerate when mutant CLRN1
proteins are expressed. Further studies of animal models exhibiting
specific gene alterations, as well as analysis of gene expression in
humans, should help to clarify the normal and pathological roles of
CLRN1 in these sensory tissues.
The USH3A Gene, Clrn1, Is Expressed in Mu¨ller Cells in the
Inner Retina
In situ hybridization and laser capture microdissection indicate
that Clrn1 is expressed in the INL, and not in the ONL
(photoreceptors), as our original hypothesis proposed. Further
supporting this unusual finding is the fact that aged animals (C3H
mice, RCS rats, and P23H-3 rats) that have completely lost their
photoreceptors continue to express Clrn1 at WT levels. If these
data hold true in humans, they imply that CLRN1 is expressed in
the INL and that proteins expressed in the inner retina, and
specifically in Mu¨ller cells, can cause RP.
The expression of Clrn1 in Mu¨ller cells was surprising. All three
sub-classifications of USH (types I, II, and III) exhibit late-onset
retinitis pigmentosa (RP). This phenotype, in general, suggests that
a slow but perpetual rod photoreceptor degeneration underlies
disease progression. Our original hypothesis stated that Clrn1
would be expressed in photoreceptors, and that the protein,
CLRN1, would be targeted to rod photoreceptor synapses and
contribute to synaptic adhesion and/or structure. Although
significant variability exists among affected individuals, on
average, USH3 patients exhibit a 50% functional vision loss at a
mean age of 28 [11] and commonly have ‘‘tubular vision’’ by the
age of 30 [9]. This is in contrast to numerous other recessive RP
(or rod-cone) diseases, in which the onset is often in the first to
second decade of life [38]. The discovery that Clrn1 is expressed in
a developmentally regulated manner in Mu¨ller cells, and that Clrn1
is not expressed in photoreceptors, was unexpected. Taken
together, our data suggest that an INL protein (CLRN1), when
mutated in humans (but not mice), results in degeneration of rod
photoreceptors. Assuming that Clrn1 is similarly localized to
Mu¨ller cells in the human retina, we believe this to be the first
instance of an INL transcript resulting in inherited photoreceptor
degeneration [10].
CLRN1 Protein Expression
Immunocytochemical detection of CLRN1 protein in retinal
tissues has not been successful. Two antibodies (one developed in
rabbit, one in chicken) accurately detected an EGFP-CLRN1
fusion protein transiently expressed by HEK293 cells (Figure S4).
Moreover, the CLRN1-B2 antibody specifically detected protein
bands at approximately the correct (predicted) molecular weight(s)
in human, rat, and mouse retinal homogenates (Figure S4L).
Immunoprecipitation (IP) with the CLRN1-B2 antibody indicates
that CLRN1 may form higher molecular weight multimers and/or
participate in a multi-protein complex, similar to complexes
previously proposed [16,60], although none of the other USH-
related proteins appear to be co-expressed in Mu¨ller glia.
In side-by-side comparisons with Clrn1 KO tissue samples,
neither of our CLRN1 antibodies that demonstrated good
specificity in vitro (Figure S4) offered a reliable immunohistochem-
ical signal in WT retinal tissue sections (Figure S5). Similar non-
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specific staining was obtained with CLRN1-B2 antibody in
human, monkey, rabbit, cat, and rat retinas (data not shown).
These data suggest that CLRN1 might be expressed at very low
levels in the retina.
Similarly, other published data using CLRN1 antibodies that
work well on western blots and on expressed CLRN1 protein in
vitro do not provide specific localization of the CLRN1 protein on
retinal tissue sections by immunocytochemistry [23]. Taken
together, these data suggest that antibody access to protein
epitopes exposed on the short extracellular and intracellular loops
of CLRN1 may be limited. It is known that tetraspanins protrude
only 4–5 nm from the plasma membrane [61,62]. Additionally,
tetraspanins are known to function as organizers of multi-
molecular membrane complexes [56], similar to USH protein
complexes [3,16,57,58]. One explanation for the lack of results by
immunocytochemistry on intact tissue (using the antibodies that do
stain cultured cells) may be that additional proteins simply block
access of antibodies to the CLRN1 epitopes.
Clrn1 Knockout Retinas Appear Normal and Cochleas
Degenerate
It has been shown that in humans, CLRN1 mutation results in a
phenotype consistent with rod photoreceptor death and RP
[10,59]. However, in mice, histological (Figure 6) and immuno-
histochemical (Figure 7) analyses in WT (+/+) and Clrn1 KO (2/
2) animals revealed no adverse consequences of Clrn1 gene
deletion. Moreover, ERG analysis of the aged Clrn1 KO mouse
failed to demonstrate either photoreceptor (A-wave) or inner
retinal (B-wave) dysfunction (Figure S6) even at 2 years of age.
Staining of second and third order neurons (Figure 7A–7H) and
the matrix sheaths around cone photoreceptors (Figure 7I and 7J)
suggests that these cells are similarly unaffected by Clrn1 deletion.
Thus, structural and functional analyses of Clrn1 KO retinas reveal
that their retinas and their vision is normal.
In contrast, yet similar to other mouse USH KO mouse models,
the lack of CLRN1 dramatically affected cochlear structure and
function (Figure 8 and Figure S7, respectively). Using ABR in WT
C57BL/6J animals as a measure of hearing function, and similar
to other data from the Clrn1 KO mouse [22], we found Clrn1 KO
mice to be essentially deaf as early as postnatal P18 (Figure S7).
Whole mount immunostaining of WT (+/+) and Clrn1 KO (2/2)
cochlea show a severe disruption in the stereocilia of 4 month old
animals (Figure 8), with some early signs of pathology as early as
P15. Thus, in the Clrn1 KO mouse we have established another
model of USH where deafness is apparent, but blindness is absent.
The mechanism underlying the cochlear degeneration remains an
open question, and in fact, the role of clarin 1 in the inner ear is still a
mystery. Based on homology to Stargazin and its proposed four
transmembrane protein structure, CLRN1 was suggested previously
to have a role in the excitatory ribbon synapse junctions between
hair cells and cochlear ganglion cells [12]. It is interesting to note that
Clrn1 deletion results in a broader distribution of longer stereocilia in
cochlear IHCs. While degeneration of hair cells and supporting cells
is a common phenomenon in hearing impaired mouse mutants,
elongation of stereocilia is usually specific to defects in proteins
involved in actin polymerization. The elongated stereocilia present
in the Clrn1mutant mice suggest a similar role. Stereocilia contain a
rigid paracrystalline array of parallel and polarized cross-linked actin
filaments, whose length is tightly regulated, with continuous actin
turnover [63]. Many factors influence the structure of the actin core
of stereocilia, including for example, myosin activity and membrane
tension. Defects in actin polymerization and/or depolymerization
may be caused by a mutation in any one of the factors that this
dynamic process is dependent on, including any of actin’s known
interacting proteins. For example, myosin VIIa is involved in the
dynamic regulation of elongation of stereocilia, as demonstrated by
stereociliar defects inMyo7a mutant mice [64,65]. Other genes with
mutations leading to Usher syndrome encode proteins that are
expressed and are functional in the stereocilia. For example, whirlin,
associated with mutations in USH2A [18], is expressed in the
stereocilia and indeed Whrn mouse mutants have shorter stereocilia
[66]. Precise localization of clarin1 in the cochlear hair cells and
further identification of its interacting proteins [23] will be vital to
elucidating the cause for the stereociliar pathology. Our data
suggests a new, previously unexplored function for clarin1 in hair
cells.
Conclusions
Similar to most other USH mouse models, our Clrn1 KO
animal exhibits a non-syndromic phenotype. In contrast to our
original hypothesis, Clrn1 is not expressed in photoreceptor cells;
but rather, Clrn1 transcripts are produced by Mu¨ller cells, the
retinas primary glial cell. These data cannot exclude the possibility
of another developmental phase of Clrn1 expression or that Clrn1’s
expression is absolutely restricted to Mu¨ller glia. Additional studies
will be required to ascertain how CLRN1 may be participating in
the unique relationship between Mu¨ller and photoreceptor cells.
Photoreceptors in the Clrn1 knockout mice remained anatom-
ically and physiologically normal, without exhibiting any pheno-
typic characteristics of retinal degeneration. In contrast, the Clrn1
KO mouse is physiologically deaf within 2–3 weeks of birth,
although IHCs and OHCs appear largely anatomically intact at
this time point. These data suggest that loss of hearing function
precedes cell loss in the cochlea: within several months of birth, the
absence of CLRN1 protein(s) cause damage evidenced by
progressive morphological disruption, proceeding to eventual
complete loss of the primary sensory hair cells.
Taken together, these data support the notion that an Usher
protein complex [3] is required for inner ear structure and
function, but dispensable for retinal structure and function in mice.
Moreover, the presence of abnormal hair cell stereocilia in the
Clrn1 KO mouse suggests that CLRN1 may function at the apical
part of the cell in addition to (or in place of) serving a role in
synapse structure and function, as previously predicted [12]. Our
data also suggest that the cellular site of the defect in human
sensory tissues must be ascertained to design a rational therapy for
these debilitating conditions, and early diagnosis and intervention
will be critical to the success of human therapies for USH3-related
hearing and vision losses.
Materials and Methods
Knockout Mouse Production
A Clrn1 knockout mouse was generated by IngenKO, Pty. Ltd.
(Clayton, Victoria, Australia). Briefly, the targeting construct was
produced using the ET cloning system [67] with C57BL/6J
genomic DNA. The construct included loxP sites that flanked part
of the Clrn1 upstream promoter, the first exon (59 UTR and
protein coding sequence), 269 bp of the first intron, and a
neomycin resistance gene (NeoR). The targeting construct was
electroporated into C57BL/6J embryonic stem (ES) cells, and
recombinant clones were selected using G418. Selected clones
were transfected with Cre recombinase and screened by PCR for
removal of the Clrn1 gene fragment noted above. Recombined ES
cells were microinjected into BALB/c blastocysts and implanted
into pseudo-pregnant mothers. Chimeric progeny were obtained,
and highly chimeric animals were subsequently mated with
C57BL/6J mice to identify germ-line transmission of the Clrn1
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deletion. Founder animals were identified, and heterozygous
progeny were delivered to University of California, Berkeley.
Heterozygous animals were bred to generate homozygous Clrn1
KO animals. WT C57BL/6J control, Clrn1 heterozygous (+/2),
and Clrn1 homozygous (2/2) mice were maintained up to 2 years
for histological, histochemical, electrophysiological, and biochem-
ical analyses. All experiments were performed in adherence to the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research, and were also approved by the Animals Care
and Use Committee of the University of California, Berkeley.
Nucleic Acid Isolation and Reverse Transcription
Total RNA was isolated from numerous tissue sources,
including WT adult C57BL/6J mice, Clrn1 KO (2/2,+/2)
mice, C3H/HeJ (C3H) mice, WT Sprague-Dawley (SD) rats,
P23H-3 (rhodopsin mutant) transgenic rats, and Royal College of
Surgeons (RCS) rats. For adult retinas and brain regions, tissues
samples were carefully dissected from any surrounding tissue. For
fetal tissues, timed pregnancies were used, and whole fetuses,
heads, brains, eyes, or retinas were dissected. Tissues were
immediately homogenized in a 1.5 mL microfuge tube containing
100–300 mL of Tri-Reagent (Sigma-Aldrich) using a small plastic
sterile pestle (Fisher Scientific, Pittsburgh, PA). Total RNA was
extracted, precipitated, and resuspended in ddH2O according to
manufacturer’s instructions. For cultured Mu¨ller cell studies (a gift
from Vijay Sarthy), 6-well or 10 cm plates of cells were grown to
near confluence, and total RNA was isolated using an RNeasy kit
(Qiagen Corp., Valencia, CA) per the manufacturer’s instructions.
Purity was assessed and total RNA was quantified with 260 and
280 nm light. RNA was reverse transcribed using M-MLV reverse
transcriptase (Promega) according to manufacturer’s instructions.
A standard reverse transcription reaction was performed for
2 hours at 37uC, and included 25–50 ng/mL input total RNA.
After the 2 hour transcription reaction, samples were stored at
220uC until used for PCR reactions.
Reverse Transcription and Polymerase Chain Reaction
All oligonucleotide DNA primers (Figure S1) were ordered from
Operon Technologies (Huntsville, AL). Multiple mouse-specific
primer pairs were designed to elucidate Clrn1 splice variant
expression, developmental expression, and tissue distribution.
Total RNA samples were reverse transcribed using M-MLV
reverse transcriptase. Twenty-five to 50 ng of cDNA was used as
template in all reactions, and all were amplified for 30 cycles,
utilizing a 65uC annealing temperature. Polymerase chain reaction
(PCR) was performed according to standard thermocycling
conditions, using 2.5 mM Mg++, 200 nM primers, 0.1 U Taq
Polymerase, 200 nM dNTPs, and 1X PCR buffer. Cycling
conditions were typically 60uC for 30’’ (annealing), 72uC for 19
(extension), and 94uC for 20’’ (melting) for 30–35 cycles. Reaction
products were electrophoresed through 1–2% agarose gels
containing 100 ng/mL ethidium bromide, buffered by Tris-
Acetate, pH 8.0, and photographed on a Kodak EDAS 290
imaging system (Fisher Scientific).
Real-Time Quantitative RT–PCR
Quantitative real-time RT-PCR was used to compare expres-
sion of the two primary splice variants, and for quantitative gene
expression in the C3H/HeJ (C3H) mouse retina. For splice variant
analysis, FAM/BHQ probes (Biosearch Technologies, Novato,
CA) were designed to span exon splice junctions (probes crossed
the exon 1/3 or exon 1/4 junctions) in order to distinguish
between the highly similar transcripts. Expression was normalized
to 28S ribosomal RNA for all 6 WT mice. For quantitative gene
expression in animal models of retinal degeneration (C3H mice,
RCS and P23H-3 rats), SYBR green was the reporter molecule
used to assess expression of several retinal transcripts: cFos, Slc1a3,
Grm1, Rhod, Rp-1, Thy1, Clrn1, and Vim. Two eyes for each strain/
genotype were assayed, each measured in duplicate, and the
average expression levels are shown. Amplification, detection, and
quantification were performed on an Mx3000P real-time thermo-
cycler (Stratagene Corp., La Jolla, CA). Refer to Figure S1 for
primers used. Twenty-five or 50 ng of cDNA was included in each
reaction, along with 300 nM primers (final concentration) and 2X
Power SYBR Green PCR Master Mix (Applied Biosystems, Foster
City, CA). The reactions were cycled 45 times with a final melting
curve analysis at the end of the experiments to qualify primer
specificity. All primer pairs showed single peaks in the melting
curve analysis (data not shown).
In Situ Hybridization
Animals were housed in the Department of Comparative
Medicine at the University of Washington and were euthanized
according to approved protocols. Timed pregnant female mice
were sacrificed and embryos removed at E18.5. The embryos were
fixed in a modified Carnoy’s solution (60% ethanol:4% formal-
dehyde:10% acetic acid) overnight at 4uC. The samples were
washed and dehydrated in 100% ethanol overnight at 4uC, and
then were embedded in paraffin and 6 micrometer sections were
collected. For the postnatal ages, we noted the day of birth as P0
and sacrificed pups at P0 and P3 according to approved protocols.
We then dissected the retinas from the animals, and fixed them
and processed them for paraffin sectioning as described above. At
least 3 animals were examined at each time point. Mouse Clrn1
cDNA (clone ID: 40130533) to exons 1 and 4, including 154 bp
and 646 bp of 59 and 39 UTR sequence was obtained from Open
Biosystems Inc. Digoxigenin (DIG)-labeled probes were prepared
according to the manufacturer’s manual for DIG-11-UTP (Roche,
Indianapolis, IN) and the hybridization was carried out according
to Hayashi et al. [68]. The in situ product was visualized using
anti-DIG alkaline phosphatase conjugated secondary antibody
(Roche) and NBT/BCIP liquid substrate system (Sigma, St. Louis,
MO). After ISH, the slides were fixed with 4% paraformaldehyde
for 1 hour and washed in PBS. The slides were then incubated
with 10% fetal bovine serum and 2% nonfat dry milk in PBS/
0.1% Triton X-100 (PBST) for 30 minutes. After an overnight
incubation with the primary rabbit antibody (anti-Glast,
#AB1782, Millipore Corp., Billerica, MA) at 1:200 dilution, or
rabbit anti-beta-tubulin III (TuJ1, Covance, Austin, TX) at 1:300
dilution, the slides were washed and incubated in fluorescent
conjugated secondary antibody, rinsed with PBST and mounted
under a cover glass with Fluoromount G (Southern Biotechnology,
Birmingham, AL). Images were captured with a Zeiss Axioplan
microscope using a SPOT CCD camera (Diagnostic Instruments,
Sterling Heights, MI) and similarly processed using Adobe
Photoshop (Adobe Systems, San Jose, CA).
Laser Capture Microdissection
LCM was used to isolate total RNA from the three nuclear
layers of the retina: outer nuclear layer (ONL), INL, and ganglion
cell layer (GCL). Briefly, whole eyes were enucleated and
immediately frozen in tissue freezing medium in a dry ice/ethanol
slurry. Seven mm retinal sections were collected onto ProbeON
Plus microscope slides (Fisher Scientific), and stored in 70%
ethanol at -25uC. Slides were dehydrated at RT in graded ethanol
series (80%, 90%, 36100%) and 2 changes of 100% xylenes, then
air dried in a fume hood, and immediately processed with a
PixCell II laser capture system (Arcturus, Mountain View, CA).
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Laser capture was performed as previously described [69]. Total
RNA was isolated using a Pico Pure extraction kit (Arcturus)
according to manufacturer’s protocol. The optional DNAse step
was omitted, and primers that span introns were used for analysis.
Two rounds of amplification were used to increase sensitivity while
mitigating background amplification. For Rp1, the F1/R1 primer
pair was used for both rounds of amplification, whereas for Clrn1,
F2/R2 primers were used for the first round, and F1/R1 primers
were used for the second round of amplification (see Figure S1).
The second round of amplification used 1/100th of the first round
PCR product as template for the second round of PCR. Reverse
transcription was performed as described above.
Retinal Histology
Eyes for histological analysis were processed as previously
described [70]. Eyes were isolated from 9 month old littermate
Clrn1 KO and age-matched WT C57BL/6J animals after cardiac
perfusion with 2.5% formaldehyde/2% glutaraldehyde in PBS
(pH 7.4). Eyes were immersion fixed for at least 24 hours. The
samples were dissected, osmicated, washed, and dehydrated in a
graded ethanol and embedded in Epon-Araldite resin (Ted Pella,
Inc., Redding, CA). Following polymerization, 1 mm sections were
cut on a microtome (UltraCut; Leica, Deerfield, IL) and stained
with 1% toluidine blue. Images were digitally captured with a
CCD camera (Axiocam; Carl Zeiss Meditec, Inc., Thornwood,
NY) on an Axiophot II photomicroscope (Carl Zeiss, Oberkochen,
Germany).
Clarin 1 Antibody Production
Several antibody production technologies were used to generate
reagents for immunological analyses. We generated two rabbit
antibodies (Sigma-Genosys/Sigma-Aldrich, St. Louis, MO) to two
human CLRN1 peptides (59-ASGQELDKFMGEM(C)-39; aa
(amino acids) 49–61; ‘‘CLRN1-A’’) and (59-(C)GFQFPFAKSK-
DAE-39; aa 209–222; ‘‘CLRN1-B’’). New Zealand White rabbits
were injected with peptides conjugated to keyhole limpet
hemocyanin (KLH). Serum from the B-peptide showed high
specificity in vitro, and CLRN1-B2 antibodies were affinity
purified and used in immunohistochemistry, western blotting,
and IP experiments. We also generated chicken IgY antibodies by
immunizing chicken eggs with two mouse peptides (59-
KVHRLSEKIANFKE-39; aa 160-173; ‘‘Clarin160’’) and (59-
PFTKSKETETTNVA-39; aa 214-227; ‘‘Clarin214’’). Both anti-
bodies were affinity purified and tested in transfected HEK293
cells, western blotting, and immunohistochemistry.
Immunocytochemistry
Standard immunocytochemical procedures were followed.
Procedures were performed at room temperature (RT) unless
indicated otherwise. Briefly, after fixation, the cells were rinsed
once in phosphate buffered saline (PBS, pH 7.4) and twice with
PBT (PBS including 0.1% Triton X-100 detergent (Sigma-Aldrich)
and 0.1% bovine serum albumin (BSA; Sigma-Aldrich)). Antibody
dilution buffer (ADB) was made by adding 2% BSA and 1:100
normal donkey serum (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA) to PBT. The cells were blocked for 30
minutes in ADB, then primary antibodies diluted in ADB were
added following removal of the blocking buffer. After one hour,
the antibodies were removed and the cells were rinsed with PBT
36109. Finally, Cy3 conjugated secondary antibodies (Jackson
ImmunoResearch) diluted 1:500 in ADB were added to the cells
for 309. After rinsing again 36109 with PBT and 2659 with PBS,
the cover glass with cells attached was inverted onto a clean
microscope slide containing a drop of Vectashield hard set
mounting medium including DAPI (Vector Laboratories, Inc.,
Burlingame, CA). Cells were photographed on an Axiophot II
photomicroscope (Carl Zeiss) fitted with an AxioCam digital
camera and fluorescence filters for three color emission. Images
were identically post-processed using Adobe Photoshop (Adobe
Systems).
Cryosection Tissue Processing and
Immunohistochemistry
WT and Clrn1 KO mouse eyes were isolated following
euthanasia by CO2 overdose. Eyes were removed rapidly and
fixed in 10% neutral buffered formalin (NBF; Ted Pella, Redding,
CA) for at least 24 hours, rotating at 4uC. Eyes were opened and
the cornea, lens, and vitreous were removed, leaving the posterior
pole containing the retina. The posterior pole was rinsed in PBS
and equilibrated into 30% sucrose (in PBS) overnight. Eyecups
were embedded in Tissue Freezing Medium (TFS; TBS, Durham,
NC), and 12–16 mm thick sections were mounted on probe-on
plus microscope slides and air-dried. For histology, the tissue
sections were counterstained with hematoxylin. For cryosection
immunohistochemical procedures, we utilized essentially the same
reagents and concentrations as for immunocytochemistry, except
that incubation times were increased due to the diffusion of
reagents into and out of the thicker tissue samples. For CLRN1-B2
immunohistochemistry (Figure S5), 12 mm thick cryosections were
used. Briefly, sections were thawed, blocked with 5% normal
donkey serum in PBT and incubated with primary antibodies
diluted in PBT overnight at 4uC. Sections were rinsed and
incubated in secondary antibodies (anti-rabbit Cy3), rinsed again
and visualized on a Zeiss Axiophot 2 confocal microscope (Carl
Zeiss).
Thick-Section Confocal Microscopy
Tissue processing for confocal microscopy was performed as
described previously [71]. Briefly, eyes and subsequently anterior
eye structures were removed, and posterior poles were immersion
fixed in 10% NBF for at least 2 hours. Whole retinas were gently
removed from the eyecups following severing of the optic nerve
head. Retinas were rinsed well with PBS, and embedded in low-
melting temperature agarose (5%) at ,40uC. After cooling, the
agarose blocks were sectioned on a Leica vibratome at 100 mm,
and collected in PBS. Sections were selected and placed into
antibody dilution buffer (ADBX (TNTB; 100 mM Tris (pH 7.4),
150 mM NaCl, 0.1% BSA, 0.1% Triton X-100) plus 1% BSA and
1% normal donkey serum). Sections were incubated for at least
16 hours at 4uC with gentle rocking. The following day, the
blocking solution was removed and primary antibodies diluted in
ADBX were added for another ,16–24 hour incubation, rocking
at 4uC. Several primary antibodies were used, including: the lectin
peanut agglutinin (PNA)-Rhodamine (Sigma-Aldrich, St. Louis,
MO), anti-synaptophysin (mouse monoclonal, 1:500, DAKO
North America Inc., Carpinteria, CA), anti-vimentin (mouse
monoclonal, 1:500, DAKO), anti-GFAP (rabbit polyclonal, 1:500,
DAKO), anti-PKCalpha (rabbit polyclonal, 1:250, Biomol, Ply-
mouth Meeting, PA), anti-Calbindin (rabbit polyclonal ab11426,
1:250, Abcam Inc., Cambridge, MA), and custom anti-CLRN1
antibodies (see above) generated in rabbits and chickens (1:100–
1:500). The following morning, the primary antibodies were
removed, and the tissue sections were rinsed briefly with PBS,
36159 in TNTB, and once for 2 hours in TNTB (rocking during
each rinse). Following the rinsing, sections were incubated for
,16 hours in Cy3 conjugated secondary antibodies diluted in
ADBX. Sections were again rinsed as above, followed by an
additional ddH2O rinse. Sections were then counterstained with
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SYTOX Green (Invitrogen) diluted 1:1000 in ddH2O for 159,
rocking at 4uC. The sections were rinsed with ddH2O, then with
PBS for 159, and mounted under a cover glass using hard set
Vectashield (Vector Laboratories) for fluorescence without DAPI.
Cover glass was sealed with nail polish to prevent evaporation.
Sections were imaged on a Zeiss Axiophot 2 confocal microscope
(Carl Zeiss), and comparison images were identically post-
processed using Adobe Photoshop (Adobe Systems).
Western Blotting and Immunoprecipitation
Triton X-100-soluble and SDS-soluble proteins from adult
donor human, mouse, and rat retinas were isolated following
whole retinal homogenization, and quantified by BCA assay.
Twenty micrograms of total protein was boiled and loaded per
lane, electrophoresed, and transferred to a nylon membrane. The
membrane was blocked with 2% BSA in PBT, incubated in
primary antibody (CLRN1-B2) at 1:3000 (0.4 mg/mL) overnight
at RT, rinsed with PBT, and incubated in anti-rabbit alkaline
phosphatase-conjugated secondary antibody at 1:2000 for 1 hour
at RT. Following final rinsing, the blot was incubated in NBT/
BCIP (Roche) to produce a blue precipitate. For IP experiments,
we used the Seize X IP kit (Pierce Biotechnology, Rockford, IL).
The CLRN1-B2 antibody was conjugated to agarose beads by
cross linking with cyanogen bromide according to the manufac-
turer’s protocol. Approximately 200 mg of total retinal protein
(from 4 combined adult mouse retinas) was incubated overnight at
4uC with the agarose bead-bound antibodies. The beads were
washed several times, and the immunoprecipitated proteins were
eluted 3 times. Ten per cent of each eluate was loaded on each
lane of a polyacrylamide gel and processed for standard western
blotting (see above).
Electroretinography
Electroretinography was performed using standard procedures.
Briefly, mice and rats were dark adapted overnight, anesthetized
with xylazine (13 mg/ml) and ketamine (87 mg/ml) under dim red
light illumination, and maintained on a heating pad. Corneas were
locally anesthetized with 0.5% proparacaine, and pupils were
dilated with 2.5% phenylephrine and 1% atropine sulfate drops.
Full field scotopic electroretinograms (ERGs) were acquired
following 10 ms flashes of white light delivered by an Espion
Colorburst mini-Ganzfeld stimulator (Diagnosys LLC, Littleton,
MA). Retinal responses were recorded using gold wire corneal
contact lens electrodes. A 6-step stimulation protocol was used
with intensities ranging from -4 log candela second per square
meter (cd.s/m2) to 1 log cd.s/m2. Three responses were recorded
and averaged for each stimulus intensity level. A-wave amplitude
was measured from the baseline to the first negative peak. B-wave
amplitude was measured from the A-wave negative peak to the
most positive peak. WT (2/2) and Clrn1 KO mice aged up to 24
months were subjected to ERG analysis. At least six animals were
recorded for each genotype at each age. Data were analyzed using
Student’s t-test. Recording traces were averaged for each light
intensity level, and error bars represent one standard deviation.
Cochlear Immunohistochemistry
For whole mount immunohistochemistry, samples were fixed in
4% PFA overnight at 4uC and then washed with PBS. Auditory
(from middle and apical turn of cochlea) and vestibular sensory
epithelia were isolated and then incubated with 0.05% Triton in
10% normal donkey serum (NDS) for 1 hour at RT. Tissues were
incubated overnight with rabbit anti-myosin VI primary antibody
(Proteus Biosciences, Ramona, CA) at a dilution of 1:200 in a
green buffer (Dyna Scientific, Logan, UT). The tissues were then
washed and incubated for 2 hours at RT with a secondary
antibody conjugated to AlexaFlour488 and rhodamine-conjugated
Phalloidin (Invitrogen - Molecular Probes, Carlsbad, CA), and
after final rinsing were mounted with fluorescent mounting
medium (GBI-Golden Bridge International, Mukilteo, WA). All
images were acquired on a Leica Confocal Microscope TCS-SP5.
Cochlear Quantitative Measurement Analysis
The length of the stereocilia from the tallest row of the inner
hair cells bundle was measured using Image J (http://rsbweb.nih.
gov/ij/) and used for quantitative analyses. A minimum of 8
images of inner hair cells were acquired from the mid-apex turn of
the cochlea (60–80% of the cochlear length) from three different
animals of each genotype. All images were taken with the same
magnification and exposure parameters. t-tests were performed
using SPSS software.
Auditory Brainstem Response
Brainstem responses were recorded for Clrn1 KO and WT
C57BL/6J mice between P16 and P42. Following deep anesthesia
using ketamine and xylazine, animals were maintained on a
warming pad, and three needle electrodes (recording, reference,
and ground) were inserted subcutaneously. Tone pips (3 ms
duration, frequencies at 8, 16, or 32 kilohertz (kHz) and intensities
at 40, 60, or 80 dB SPL (decibel sound pressure level)) were
delivered to the left ears at a rate of 19 times per second through a
calibrated earphone (Stax Ltd., Japan). ABR signals were recorded
using BioSigRP software on a Tucker Davis Technology System 3
recording rig (Alachua, FL), and 500 recordings were averaged for
each animal in each condition.
EGFP-CLRN1 Fusion Construct and Transfection
The pEGFP-C1 vector (GI:1377914; Clontech, Mountain
View, CA) was utilized for generating a fusion construct between
EGFP and CLRN1. The full-length mouse Clrn1 coding sequence
(exons 1, 3, and 4, and including a stop codon; 699 bp) was cloned
from C57BL/6J genomic DNA. The clone was sequenced and
spliced into the BamHI and EcoRI restriction sites within the
pEGFP-C1 multiple cloning site at the 39 end of, and in frame
with, EGFP. Viable fusion protein expression was evidenced by a
redistribution of fluorescence from the cytoplasm to the plasma
membrane in transfection assays (see Figure S4). HEK293 cells
were used for all transfection assays. Transfection with the EGFP-
CLRN1 construct was performed essentially as described previ-
ously [72]. Briefly, plasmid DNA was mixed with Lipofectamine
2000 (Invitrogen) and incubated with ,50% confluent HEK293
cells grown on cover glass. After 24–36 hours, the cells were fixed
in 10% neutral buffered formalin for 159, and subjected to
immunocytochemical analysis.
Supporting Information
Figure S1 Oligonucleotide primers and fluorescent probes used.
Found at: doi:10.1371/journal.pgen.1000607.s001 (0.40 MB PDF)
Figure S2 Clrn1 mRNA co-localizes with a marker for Mu¨ller
cells. (A–C) Clrn1 ISH combined with anti-Glast (Slc1a3; a Mu¨ller
glial marker) immunohistochemistry labeling shows co-labeling.
The labeling in the GCL represents Mu¨ller cell processes, which
extend to and surround cells in the GCL. (D–F) Higher
magnification view of the region in the box in H, and the arrow
points to a cluster of cells that is labeled with both Clrn1 and Glast.
Scale bars = 50 mm.
Found at: doi:10.1371/journal.pgen.1000607.s002 (1.42 MB TIF)
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Figure S3 Genetically Degenerated rat retinas express Clrn1
despite photoreceptor loss. (A,B) Photomicrographs of retinal cross-
sections from a two month old WT Sprague-Dawley rat (A) and a 1
year old P23H-3 (P23H-3; rhodopsin mutant) transgenic rat (B).
Note the apposition of the RPE and INL in the P23H retina, and
thus, a complete absence of the outer nuclear layer (ONL). Tissues
were stained with hematoxylin. (C) Using RT-PCR, both SD and
P23H rats (duplicate samples for each) express Clrn1. In contrast,
only the WT animal expresses Rp1, supporting the histological loss
of photoreceptors in the P23H animals. (D) Similar results are
observed in the RCS rat. The congenic control strain (rdy+)
expresses both Clrn1 and Rp1 by RT-PCR, whereas the RCS
mutant animals express Clrn1, but not Rp1. (E) Quantitative RT-
PCR analysis in the two rat models of photoreceptor degeneration
indicates ,100-fold reductions in the expression of Rp1. Due to
equal amounts of retinal cDNA being used in each reaction, a
relative increase in Clrn1 expression is observed in mutant animals
due to the loss of photoreceptor mRNA in the total retinal RNA
pool used for cDNA synthesis. Data represent the averages of two
animals in each condition. Scale bar= 50 mm.
Found at: doi:10.1371/journal.pgen.1000607.s003 (1.04 MB TIF)
Figure S4 Clarin 1 localizes to the plasma membrane in
transiently transfected HEK293 cells, and anti-CLRN1 antibodies
specifically detect CLRN1. Clarin 1 Localizes to the Plasma
Membrane in Transiently Transfected HEK293 Cells, and Anti-
CLRN1 Antibodies Specifically Detect CLRN1. (A) Transfection
with the pEGFP-C1 parent plasmid alone results in bright green
cytoplasmic fluorescence in HEK293 cells. (B) The mouse Clrn1
cDNA (exons 1, 3, and 4) was cloned in-frame with EGFP.
Following transfection, the EGFP-CLRN1 fusion protein caused
the redistribution of EGFP (green fluorescence) from the cytoplasm
to the plasma membrane. (C–E) CLRN1-B2 antibody staining of
HEK293 cells transfected with the EGFP-CLRN1 fusion protein.
The merged image (E) shows near perfect co-localization (yellow).
Cells were counterstained with DAPI. (F–H) HEK293 cells were
transfected with the EGFP-CLRN1 fusion protein construct and
immunostained with a different anti-CLRN1 antibody (Clarin160).
(I–K) Cells were transfected with the EGFP-CLRN1 fusion protein
construct and immunostained with secondary antibodies alone.
Only green fluorescence originating from EGFP is visible. (L)
Western blot using the CLRN1-B2 antibody on human (H), mouse
(M), and rat (R) retinal homogenates, with and without SDS in the
sample buffer, including BME. The CLRN1-B2 antibody detects a
,26 kDa band in mouse and rat, and a doublet of ,25 kDa and
,34 kDa in the human retinal sample.
Found at: doi:10.1371/journal.pgen.1000607.s004 (2.01 MB TIF)
Figure S5 Immunostaining of P7 WT and Clrn1 KO mouse
retinal sections. (A–H) Similar staining patterns were observed in
WT and Clrn1 KO P7 retinal tissues immunostained with GFAP
(A–B), vimentin (C–D), Clarin160 (E–F), and CLRN1-B2
antibodies. Though there may be a slight reduction in labeling
in the Clrn1 KO mouse (F and H), non-specific (background)
staining in the tissues prevents reliable use of either anti-CLRN1
antibody to specifically localize CLRN1 in the retina. Scale
bar = 20 mm. ONL=outer nuclear layer, INL= inner nuclear
layer, and GCL= ganglion cell layer.
Found at: doi:10.1371/journal.pgen.1000607.s005 (2.74 MB TIF)
Figure S6 Electroretinograms of WT and Clrn1 KO (2/2) mice
at 18 months of Age. (A,B) White traces represent WT C57BL/6J
mice, while black traces represent Clrn1 KO (2/2) mice. (A) Peak
A-wave voltage (mV) responses to increasing light intensities (log
cd.s/m2), from left to right. (B) Peak B-wave voltage responses to
increasing light intensities, from left to right. Both A- and B- waves
are similar for the WT and Clrn1 KO (2/2) animals. (C) Graph
illustrating voltage changes vs. time for both the WT and Clrn1
KO (2/2) animals. Error bars = 1 SD.
Found at: doi:10.1371/journal.pgen.1000607.s006 (0.13 MB TIF)
Figure S7 Auditory brainstem response recordings of inner ear
function. (A) Ten millisecond (ms) auditory brainstem responses
(ABR) in WT C57BL/6J and Clrn1 KO (2/2) mice at 6 weeks of
age. Averaged traces are shown for five animals in each condition,
exposed to 3 sound intensities (40, 60, and 80 dB SPL) at three
frequencies (8, 16, and 32 kHz). Clrn1 KO animals exhibit a
profound diminution in their brainstem responses at all the dB
SPL levels tested, and tonal frequency had no effect on the ABR.
(B) Ten ms 80 dB SPL Auditory Brainstem Response (ABR)
recordings from WT C57BL/6J (P16) and Clrn1 KO (P18) mice.
Five animals were recorded for each genotype; individual traces
are shown on the left, and averaged curves are shown on the right.
Even at this early age, Clrn1 KO animals show severely depressed
ABR sensitivities. A 1 ms bar is shown for reference.
Found at: doi:10.1371/journal.pgen.1000607.s007 (0.17 MB TIF)
Figure S8 P120 vestibular hair cells of Clrn1 KO mice appear
unaffected. (A–D) Immunofluorescent confocal images of inner ear
sensory maculae harvested from utricles. Samples were labeled
with rhodamine-Phalloidin and are shown at low (A and B) and
high (C and D) magnification. Clrn1 KO mice show a grossly
normal utricular elliptical shape (B) with classical distribution of
hair cells (D). Scale bars: In A (200 mm) applies to A and B; in C
(20 mm) applies to C and D.
Found at: doi:10.1371/journal.pgen.1000607.s008 (0.33 MB TIF)
Video S1 An Aged Homozygous Clrn1 KO (2/2) Mutant
Mouse Displaying Circling Behavior.
Found at: doi:10.1371/journal.pgen.1000607.s009 (3.78 MB
MOV)
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